2021 in review, and happy new year 2022
This past year, we have largely focused on following through on our commitment to take on SARS-CoV-2. Looking ahead, there’s more work to be done on the pandemic, and we…
Read moreThis past year, we have largely focused on following through on our commitment to take on SARS-CoV-2. Looking ahead, there’s more work to be done on the pandemic, and we…
Read moreRev up your GPUs and help us in the final stretch of nominating a patent-free oral antiviral for preclinical studies!
Read moreFolding@home helps experimental collaborators understand mutations that drive increased fitness of SARS-CoV-2 mutants.
Read moreWe’re thrilled to report that the COVID Moonshot has been awarded a $10M grant from the Wellcome Trust on behalf of the World Health Organization (WHO) Access to COVID Tools…
Read moreSprint 10 aims to help optimize the P1 pocket substituent to work around metabolism issues with our current best lead compounds. We’ve been quiet lately, but that’s because we’ve been…
Read moreTL;DR: During 2020, Folding@home was like the citizens’ fleet in the movie Star Wars: The Rise of Skywalker. Everyone came together to face a common foe, in this case the…
Read moreAs we all know, coronaviruses are a major threat to human health. In the past two decades these viruses have caused three epidemics: SARS in 2004, MERS in 2012, and…
Read moreSprint 5 to prioritize compounds for the open science patent-free COVID Moonshot drug discovery project has launched! Rev up your GPUs to help develop a new therapy.
Read moreSeveral antibodies are now in clinical trials to both treat and provide protection against COVID-19. But one of these binds in a completely surprising way, and in a manner that may head off viral resistance. How does it work? We’re trying to find out!
Read moreAs the COVID Moonshot continues to make rapid progress, the fourth free energy sprint focused on a backup lead series that suddenly pulls into the lead!
Read more